Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Berwyn, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Virpax Pharmaceuticals, Inc. has filed 278 SEC EDGAR filings since 05 Apr 2018

SEC filing history

Showing 201-225 of 278 matching filings.

Per page
25
Current page
9
4

4 filing

Filing date
05 Jan 2022
Reporting date
01 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Jan 2022
Reporting date
01 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92861

SABBY 13G-A VRPX 1.04.22

Filing date
04 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Nov 2021
Reporting date
22 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Nov 2021
Reporting date
18 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40064

CURRENT REPORT

Filing date
15 Nov 2021
Reporting date
15 Nov 2021
Next action
Verify source filing
10-Q File 001-40064

QUARTERLY REPORT

Filing date
15 Nov 2021
Reporting date
30 Sep 2021
Next action
Verify source filing
SC 13G File 005-92861

SABBY 13G VRPX 9.23.21

Filing date
23 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92861

SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP

Filing date
21 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92861

SCHEDULE 13G

Filing date
20 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS EX File 333-259421

POST EFFECTIVE AMENDMENT NO.1 TO FORM S-1

Filing date
15 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-259421

PROSPECTUS

Filing date
15 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-259421

EFFECT filing

Filing date
14 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-259421

FREE WRITING PROSPECTUS

Filing date
10 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
09 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
09 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-259421

REGISTRATION STATEMENT

Filing date
09 Sep 2021
Reporting date
Not listed
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
09 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS File 377-05434

DRS filing

Filing date
01 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40064

CURRENT REPORT

Filing date
10 Aug 2021
Reporting date
10 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-40064

QUARTERLY REPORT

Filing date
10 Aug 2021
Reporting date
30 Jun 2021
Next action
Verify source filing
4

4 filing

Filing date
05 Aug 2021
Reporting date
26 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
05 Aug 2021
Reporting date
26 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
05 Aug 2021
Reporting date
26 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40064

CURRENT REPORT

Filing date
30 Jul 2021
Reporting date
26 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .